[Replay] The company behind the psychedelic revolution

*Sponsored by Psycheceutical Bioscience

Hey Folks,

If you couldn’t watch it on October 19th, what a pity.

My LIVE and exclusive interview with Chad Harman, CEO of Psycheceutical Bioscience, was dynamic, engaging, and deeply informative. The chatroom was abuzz with questions and Chad didn’t disappoint!

Still, not all is lost. You can watch the recording right here (or click on the image below).

And based on the work that this company is doing – and the information Chad shared with us – I urge you to pay close attention. I think there’s a great investment opportunity here, what about you?

Psycheceutical has been named a TOP Biotech Startup of 2023 by LifeSciences Review. Why? It’s using cutting-edge technology to bring psychedelics and pharmaceutics together so that the medical profession can be confident in prescribing these drugs to sufferers.

It’s doing this by creating state-of-the-art drug delivery technology that enables the precise dosing required for the safe and effective treatment of depression, PTSD, anxiety, and a host of other mental health disorders.

As Chad confirmed during our interview, the work that this company is doing is revolutionary… something Kevin Harrington of Shark Tank fame understands. He's an investor and strategic advisor to Psycheceutical. Talk about pulling out all the stops!

The details that caught my attention the most during our time together include:

• Psycheceutical is operating in a market of 300 million plus people suffering from depression, addiction, PTSD and other mental disorders. This number is only increasing because of the impacts COVID had on societies as well as the wars in Ukraine and Israel. (Stock traders – and even more so, investors – probably have PTSD as well, after how the markets have behaved since 2020!).

• The company is well into its Phase 1 trials of its Neurodirect ketamine topical for the treatment of PTSD. What’s most exciting about this is that the trials are being conducted in Australia, where they closely follow the FDA guidelines while offering companies a 43.5% government rebate for their research!

• In a breakthrough move in the psychedelic drugs space, Psycheceutical’s medicines and its patented delivery systems make it possible for doctors and nurse practitioners to prescribe it without any psychologist or psychiatric involvement! This significantly reduces the time and cost involved, making it more accessible to those who need it most.

• It has TWO great revenue tracks: Licensing its drug delivery system and creating its own formulations.

• And so much more!

Even if you were able to watch this interview live on October 19, do yourself a favor and watch it again. There is just so much interesting and valuable information in here… not only for potential investors, but also for anyone with personal experience with mental disorders.

Trading on the OTC as BWVI, Psycheceutical is conducting a Reg CF campaign through Wefunder to further its research and development. This offering gives new investors favorable terms and a better entry price than simply going directly to the exchange.

👉Investors can grab exclusive “Friends Invest First” benefits, including a 25% discount to market, and can invest for as little as $250.

This early bird offer is only available for a limited time (as I write this, you only have 11 days left to take advantage!!!).

This means that you do NOT need to be an accredited investor to grab a seat on this train.

Why is the company raising funds via a CF if it’s already public?

I asked Chad about that. As he explains (in the video), they’re doing this to give a wider base of investors the opportunity to invest… and increasing the number of investors will allow the company to uplist to a bigger exchange. This move would have major benefits to all parties involved – the company, its investors, and sufferers of mental disorders seeking non-toxic, non-addictive solutions.

So do a deep dive into this trailblazer, and besides the Wefunder page you can access their investor presentation here.

Here’s to YOUR success,

*Sponsored content. Like all investments, this investment involves substantial risk. Please see full disclosures below.

Questions or concerns about our products? Email [email protected] © Copyright 2022, RagingBull - Refund Policy - Privacy Policy - Terms & Conditions